In extensive experiments, the new AI model demonstrated a 32.37% relative improvement in the area under the precision-recall curve (PR-AUC) for Phase I clinical trials compared to the base HINT model.

The transformative impact of artificial intelligence (AI) on clinical research, diagnosis, treatment, and our overall understanding of medicine continues to expand. This collection of in-depth ...

“Clinical trials cost billions upon billions of dollars and take many, many, many years. And AI is one of the short, most surefire ways they have of attempting to shorten and cheapen that ...

PRNewswire/ -- "According to the latest BCC Research study, the demand for "Artificial Intelligence (AI) in Life Sciences ...

Finnish pharmaceutical company Orion has entered a partnership with Aitia to leverage artificial intelligence in drug ...

By improving triage, an artificial intelligence program could significantly aid emergency departments that are often ...

英矽智能创始人兼首席执行官Alex Zhavoronkov博士表示：“ ...

In the completed Phase 1/2a clinical trial (NCT03715985), assessing EVX-01 in combination with a PD-1 inhibitor, eight of twelve metastatic melanoma patients (67%) had objective clinical responses ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib ... enough to warrant discontinuing treatment. A new preclinical model using CRISPR, an advanced technology ...

Pharmaceutical Technology has compiled a list of companies that assist with clinical research, formulation development, pre-clinical trials, clinical manufacturing, clinical trials, and regulatory ...

Investorideas.com ( a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, ...